177 related articles for article (PubMed ID: 20495367)
1. Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival.
Hsu HP; Shan YS; Lai MD; Lin PW
Cancer Biol Ther; 2010 Jul; 10(2):144-54. PubMed ID: 20495367
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.
Zhao XQ; Dong JH; Zhang WZ; Liu Z
Diagn Pathol; 2011 Oct; 6():98. PubMed ID: 21992455
[TBL] [Abstract][Full Text] [Related]
3. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
[TBL] [Abstract][Full Text] [Related]
4. Nestin predicts a favorable prognosis in early ampullary adenocarcinoma and functions as a promoter of metastasis in advanced cancer.
Shan YS; Chen YL; Lai MD; Hsu HP
Oncol Rep; 2015 Jan; 33(1):40-8. PubMed ID: 25371063
[TBL] [Abstract][Full Text] [Related]
5. Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia.
Chen MC; Chen YL; Wang TW; Hsu HP; Lai MD
Oncol Rep; 2016 Oct; 36(4):1997-2008. PubMed ID: 27510297
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
7. Mucins differently expressed in various ampullary adenocarcinomas.
Wang T; Liang YM; Hu P; Cheng YF
Diagn Pathol; 2011 Oct; 6():102. PubMed ID: 22027009
[TBL] [Abstract][Full Text] [Related]
8. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
9. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.
Vincenzi B; Santini D; Perrone G; Russo A; Adamo V; Rizzo S; Castri F; Antinori A; Alloni R; Crucitti PF; Morini S; Rabitti C; Vecchio FM; Magistrelli P; Coppola R; Tonini G
Ann Oncol; 2009 Jan; 20(1):78-83. PubMed ID: 18689862
[TBL] [Abstract][Full Text] [Related]
11. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.
Wu CL; Chao YJ; Yang TM; Chen YL; Chang KC; Hsu HP; Shan YS; Lai MD
BMC Cancer; 2015 Nov; 15():903. PubMed ID: 26572077
[TBL] [Abstract][Full Text] [Related]
12. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 Independently Predicts Worse Survival of Patients With Adenocarcinoma of the Ampulla of Vater.
Kim HG; Park MS; Sung JY; Kim YW; Kim HS; Na K
Anticancer Res; 2019 Sep; 39(9):4947-4955. PubMed ID: 31519600
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer.
Sideras K; Biermann K; Yap K; Mancham S; Boor PPC; Hansen BE; Stoop HJA; Peppelenbosch MP; van Eijck CH; Sleijfer S; Kwekkeboom J; Bruno MJ
Int J Cancer; 2017 Aug; 141(3):572-582. PubMed ID: 28470686
[TBL] [Abstract][Full Text] [Related]
16. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
17. Gene expression profiling identifies markers of ampullary adenocarcinoma.
Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
[TBL] [Abstract][Full Text] [Related]
18. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.
Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
